Reason for request
Inclusion
Clinical Benefit
| Substantial |
The actual benefit of NOVOEIGHT is substantial. |
Clinical Added Value
| no clinical added value |
NOVOEIGHT does not provide any improvement in actual benefit (level V, non-existent) in the treatment and prophylaxis of haemophilia A compared with other available treatments. |
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
R8rbKmv2mTWeVXpK
